Resources with keywords: paxlovid
The majority of Omicron sublineages circulating in the United States have reduced susceptibility to the monoclonal antibody, bebtelovimab and the monoclonal antibody combination, cilgavimab and tixagevimab (EvusheldTM). Antiviral therapeutics for the treatment of COVID-19, ritonavir-boosted nirmatrelvir (Paxlovid™), remdesivir (Veklury®), and molnupiravir (Lagevrio™), retain activity against currently circulating Omicron sublineages.
Shah MM, Joyce B, Plumb ID, et al.
A new way to get tested for Covid and treated at the same site, if appropriate. People who test positive at home can also bring those tests to the sites to be evaluated for treatment.